Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures.

Literature DB >> 14969080

A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures.

J S Smolen¹, T Sokka, T Pincus, F C Breedveld.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2003 PMID： 14969080

Source DB: PubMed Journal: Clin Exp Rheumatol ISSN： 0392-856X Impact factor: 4.473

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Patients with rheumatoid arthritis in clinical care.

Authors: J S Smolen; D Aletaha
Journal: Ann Rheum Dis Date: 2004-03 Impact factor: 19.103

2. Leflunomide/chloroquin combination therapy in rheumatoid arthritis: a pilot study.

Authors: Bernhard Rintelen; Ingrid Andel; Judith Sautner; Burkhard F Leeb
Journal: Clin Rheumatol Date: 2006-01-04 Impact factor: 2.980

3. Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology.

Authors: X Le Loët; J M Berthelot; A Cantagrel; B Combe; M De Bandt; B Fautrel; R M Flipo; F Lioté; J F Maillefert; O Meyer; A Saraux; D Wendling; F Guillemin
Journal: Ann Rheum Dis Date: 2005-06-30 Impact factor: 19.103

4. Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study.

Authors: M Schoels; T Kapral; T Stamm; J S Smolen; D Aletaha
Journal: Ann Rheum Dis Date: 2007-02-16 Impact factor: 19.103

Review 5. Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects.

Authors: Josef S Smolen; Kurt Redlich; Jochen Zwerina; Daniel Aletaha; Günter Steiner; Georg Schett
Journal: Clin Rev Allergy Immunol Date: 2005-06 Impact factor: 8.667

6. Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden.

Authors: N J Bansback; A Brennan; O Ghatnekar
Journal: Ann Rheum Dis Date: 2004-11-18 Impact factor: 19.103

Review 7. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Authors: Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maxime Dougados; Paul Emery; Cecile Gaujoux-Viala; Simone Gorter; Rachel Knevel; Jackie Nam; Monika Schoels; Daniel Aletaha; Maya Buch; Laure Gossec; Tom Huizinga; Johannes W J W Bijlsma; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Cem Gabay; Juan Gomez-Reino; Marios Kouloumas; Tore K Kvien; Emilio Martin-Mola; Iain McInnes; Karel Pavelka; Piet van Riel; Marieke Scholte; David L Scott; Tuulikki Sokka; Guido Valesini; Ronald van Vollenhoven; Kevin L Winthrop; John Wong; Angela Zink; Désirée van der Heijde
Journal: Ann Rheum Dis Date: 2010-05-05 Impact factor: 19.103